Clinical pharmacology in drug development
Assessment of Pharmacokinetic Drug Interaction of Asciminib with Atorvastatin in Healthy Participants.
Matthias Hoch, Wendy Weis, Felix Huth, Seshulatha Jamalapuram, Michelle Quinlan, Amarnath Bandaru, Suleyman Eralp Bellibas, Asmae Mirkou, Shruti Kapoor, Shefali Kakar
Published: 202510.1002/cpdd.1611
Abstract
Asciminib is the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP) in patients with chronic myeloid leukemia. This phase 1, two-treatment-period, drug-drug interaction study evaluated the effect of steady-state asci…
Preview only. Read the full abstract at the source